Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

1.1K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.1K
Seizures: Classification01:13

Seizures: Classification

1.3K
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.3K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

804
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
804

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Machine learning based variance estimation under two phase sampling using health and education sector data.

Scientific reports·2026
Same author

A novel flexible exponent power-X family of distributions with applications to COVID-19 mortality rate in Mexico and Canada.

Scientific reports·2024
Same author

Selective reporting in clinical trials: analysis of trial protocols accepted by The Lancet.

Lancet (London, England)·2008
Same author

Are these data real? Statistical methods for the detection of data fabrication in clinical trials.

BMJ (Clinical research ed.)·2005
Same author

The effect of scientific misconduct on the results of clinical trials: a Delphi survey.

Contemporary clinical trials·2005

Related Experiment Video

Updated: Jan 12, 2026

Author Spotlight: Unraveling Seizure Dynamics and Novel Therapeutics for Status Epilepticus Using CMOS High-Density Microelectrode Array Systems
06:28

Author Spotlight: Unraveling Seizure Dynamics and Novel Therapeutics for Status Epilepticus Using CMOS High-Density Microelectrode Array Systems

Published on: September 27, 2024

3.2K

Advancing epileptic seizure recognition through bidirectional LSTM networks.

Sanaa Al-Marzouki1

  • 1Department of Statistics, Faculty of Science, King Abdul Aziz University, Jeddah, Saudi Arabia.

Frontiers in Computational Neuroscience
|November 3, 2025
PubMed
Summary

This study introduces a deep learning model using bidirectional Long Short-Term Memory (BiLSTM) networks for enhanced epileptic seizure detection. The BiLSTM model achieved 98.70% accuracy, significantly outperforming traditional methods in identifying seizures from EEG data.

Keywords:
EEG analysisbidirectional LSTMbrain stimulationdeep learningepileptic seizure recognitionhealthcare technologyneural networksneurological disorders

More Related Videos

Using a Bipolar Electrode to Create a Temporal Lobe Epilepsy Mouse Model by Electrical Kindling of the Amygdala
09:49

Using a Bipolar Electrode to Create a Temporal Lobe Epilepsy Mouse Model by Electrical Kindling of the Amygdala

Published on: June 29, 2022

3.1K
Simultaneous Eye Tracking and Single-Neuron Recordings in Human Epilepsy Patients
07:43

Simultaneous Eye Tracking and Single-Neuron Recordings in Human Epilepsy Patients

Published on: June 17, 2019

8.2K

Related Experiment Videos

Last Updated: Jan 12, 2026

Author Spotlight: Unraveling Seizure Dynamics and Novel Therapeutics for Status Epilepticus Using CMOS High-Density Microelectrode Array Systems
06:28

Author Spotlight: Unraveling Seizure Dynamics and Novel Therapeutics for Status Epilepticus Using CMOS High-Density Microelectrode Array Systems

Published on: September 27, 2024

3.2K
Using a Bipolar Electrode to Create a Temporal Lobe Epilepsy Mouse Model by Electrical Kindling of the Amygdala
09:49

Using a Bipolar Electrode to Create a Temporal Lobe Epilepsy Mouse Model by Electrical Kindling of the Amygdala

Published on: June 29, 2022

3.1K
Simultaneous Eye Tracking and Single-Neuron Recordings in Human Epilepsy Patients
07:43

Simultaneous Eye Tracking and Single-Neuron Recordings in Human Epilepsy Patients

Published on: June 17, 2019

8.2K

Area of Science:

  • Neurology
  • Biomedical Signal Processing
  • Artificial Intelligence in Medicine

Background:

  • Accurate and timely seizure detection is crucial for neurological diagnosis and patient management.
  • Traditional machine learning methods struggle to capture the dynamic nature of neural signals effectively.
  • Limitations exist in conventional techniques for epileptic seizure identification.

Purpose of the Study:

  • To address limitations in traditional seizure detection methods.
  • To design and implement a deep learning model for enhanced epileptic seizure identification.
  • To improve the reliability and accuracy of seizure detection using electroencephalogram (EEG) data.

Main Methods:

  • Utilized a dataset from Kaggle's Epileptic Seizure Recognition challenge (11,500 samples, 179 features per sample).
  • Developed a deep learning model based on bidirectional Long Short-Term Memory (BiLSTM) networks.
  • Employed data preprocessing, batch normalization, dense layers, and dropout for efficient learning from EEG signals.

Main Results:

  • The proposed BiLSTM model achieved 98.70% accuracy on the validation set.
  • Demonstrated superior performance compared to traditional techniques in seizure detection.
  • Statistical metrics including F1-score, recall, and precision validated the model's effectiveness.

Conclusions:

  • Bidirectional LSTM networks significantly improve seizure identification accuracy and reliability over conventional practices.
  • The developed BiLSTM model offers end-to-end feature learning from raw EEG signals, reducing the need for extensive preprocessing.
  • This approach advances biomedical signal processing and has potential applications in real-time seizure monitoring and intervention.